Defining Acute Myeloid Leukemia Ontogeny in Older Patients

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Elderly acute myeloid leukemia (AML) patients face poor prognoses.
• Secondary AML (sAML) often develops from antecedent hematologic disorders (AHD).

Purpose of the Study:

• To validate somatic mutations for determining AML ontogeny in elderly patients.
• To compare clinical versus molecular classifications of AML in this demographic.

Main Methods:

• Analyzed NexGen Sequencing data from 178 elderly AML patients (>70 years).
• Classified patients clinically into primary AML (pAML) or sAML based on AHD history.
• Reclassified patients into four groups based on somatic mutations and cytogenetics.

Main Results:

• Molecular classification identified more sAML cases than clinical criteria.
• Significant discordance observed between clinical and molecular classifications.
• Median overall survival varied across molecularly defined groups, with TP53 mutations associated with shorter survival.

Conclusions:

• Molecular annotation reclassifies a substantial proportion of elderly AML patients as sAML.
• This reclassification has potential therapeutic implications for AML treatment in the elderly.